Phosphate wasting in oncogenic osteomalacia: Phex is normal and the tumor-derived factor has unique properties

Bone

Volumn 28, Issue 4, 2001, Pages 430-439

  Nelson, A E ^a,b   Hogan, J J ^a,b   Holm, I A ^c   Robinson, B G ^a,b   Mason, R S ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cotransport; Hypophosphatemia; Oncogenic; Osteomalacia; PHEX; Sodium phosphate

Indexed keywords

CARRIER PROTEIN; COLCHICINE; CYCLOHEXIMIDE; CYTOCHALASIN D; PARATHYROID HORMONE; PHOSPHATE;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; OSTEOMALACIA; PHENOTYPE; PHOSPHATE TRANSPORT; TUMOR CELL CULTURE; VITAMIN D METABOLISM; VITAMIN D RESISTANT RICKETS;

BONE NEOPLASMS; CARRIER PROTEINS; COLCHICINE; CULTURE MEDIA, CONDITIONED; CYCLOHEXIMIDE; CYTOCHALASIN D; HUMANS; KIDNEY; MUTATION; OSTEOMALACIA; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHATES; PROTEINS; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE II; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 0035032073     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00417-3     Document Type: Article

References (48)

1. i cotransport and mRNA in OK cells
2. Vitamin D-resistant rickets associated with epidermal nevus syndrome; Demonstration of a phosphaturic substance in the dermal lesions
3. + phosphate cotransporter mRNA and protein-Effect of the Gy mutation and low phosphate diet
4. Brief report; Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia
5. Promoter elements of genes coding for proteins and modulation of transcription by estrogens and progesterone
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Operations and definitions
8. Mutational analysis of PHEX gene in X-linked hypophosphatemia
9. Tumor-induced osteomalacia; Unveiling a new hormone
10. Positional cloning of the PEX gene; New insights into the pathophysiology of X-linked hypophosphatemic rickets
11. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets
12. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphataemic rickets
13. i cotransport in opossum kidney cells
14. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets
15. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets
16. Gene expression profiles of tumors associated with oncogenic osteomalacia
17. Proximal tubule characteristics of cultured human renal cortex epithelium
18. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse
19. Evidence for a humoral phosphaturic factor in oncogenic hypophosphatemic osteomalacia
20. Cloning of human PEX cDNA- Expression, subcellular localization, and endopeptidase activity
21. Parathyroid hormone regulates phosphate transport in OK cells via an irreversible inactivation of a membrane protein
22. Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability
23. Hemangiopericytoma-induced osteomalacia; Tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D1-hydroxylase activity
24. i) reabsorption and of its regulation
25. The PEX gene; Not a simple answer for X-linked hypophosphataemic rickets and oncogenic osteomalacia
26. Characteristics of tumor cell bioactivity in oncogenic osteomalacia
27. Oncogenic osteomalacia; Is there a new phosphate regulating hormone?
28. Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity; Evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia
29. Addressing the tertiary structure of human parathyroid hormone-(1-34)
30. i cotransporter
31. Tumor-induced hypophosphatemic osteomalacia (TUO); Evidence for a phosphaturic cyclic AMP-independent action of tumor extract
32. The role of the PHEX gene (PEX) in families with X-linked hypophosphataemic rickets
33. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia
34. Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia
35. Oncogenous osteomalacia; Review of the world literature of 42 cases and report of two new cases
36. Parathyroid hormone-like bioactivity in tumours from patients with oncogenic osteomalacia
37. i cotransporter from opossum kidney cells
38. Cellular and molecular mechanisms of renal phosphate transport
39. Recent advances in epithelial sodium-coupled phosphate transport
40. X-linked hypophosphataemia; A homologous disorder in humans and mice
41. +-phosphate cotransport in murine X-linked hypophosphatemic rickets; Molecular characterization
42. Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23
43. Autosomal dominat hypophosphatemic rickets is caused by mutations in a novel gene, FGF21, that shares homology with the fibroblast growth factor family
44. Oncogenic osteomalacia; Evidence for a humoral phosphaturic factor
45. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain